Niagen Bioscience, Inc. (NAGE) valuation · P/E 13, rev $129.4M
Niagen Bioscience, Inc. (NAGE) P/E 13, rev $129.4M.
| Metric | Value |
|---|---|
| P/E | 13 |
| Market cap | $836.5M |
| Revenue | $129.4M |
| P/S | 6.5 |
NAGE valuation FAQ
What is NAGE's P/E ratio?
Niagen Bioscience, Inc. (NAGE) trailing P/E is 13 on the latest cached fundamentals snapshot.
What is NAGE's market cap?
Niagen Bioscience, Inc. (NAGE) market cap is $836.5M on the latest cached fundamentals snapshot.
What is NAGE's latest revenue?
Latest cached Niagen Bioscience, Inc. (NAGE) revenue was $129.4M. Statements: https://lician.com/financials/nage
What is NAGE's price-to-sales ratio?
Niagen Bioscience, Inc. (NAGE) price-to-sales (P/S) is 6.5, cached market cap $836.5M divided by revenue $129.4M.
How many NAGE valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Niagen Bioscience, Inc. (NAGE): P/E, Market cap, Revenue, and P/S.
Where is NAGE valuation listed?
Cached valuation multiples for Niagen Bioscience, Inc. (NAGE) are listed at https://lician.com/valuation/nage.
Not investment advice. Cached rows, not a live tape.